Maternal Use of Acetaminophen, Ibuprofen, and Acetylsalicylic Acid During Pregnancy and Risk of Cryptorchidism
暂无分享,去创建一个
Henrik Toft Sørensen | Jens Peter Bonde | Jørn Olsen | H. Sørensen | J. Olsen | J. Bonde | G. Toft | T. Henriksen | A. Thulstrup | M. Jensen | Gunnar Toft | Ane Marie Thulstrup | Morten Søndergaard Jensen | Cristina Rebordosa | Tine Brink Henriksen | C. Rebordosa | M. S. Jensen
[1] Jorma Toppari,et al. Acquired cryptorchidism is frequent in infancy and childhood. , 2009, International journal of andrology.
[2] J. Barthold,et al. Genetic and environmental contributors to cryptorchidism. , 2009, Pediatric endocrinology reviews : PER.
[3] A. Gurjar,et al. Effect of Prostaglandins A‐1, E‐2 and F‐2a on Blood Plasma Levels of Testosterone, LH and FSH in Male Rats , 2009, Andrologia.
[4] B. Anderson. Paracetamol (Acetaminophen): mechanisms of action , 2008, Paediatric anaesthesia.
[5] Edward E Knaus,et al. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. , 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[6] M. Kogevinas,et al. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. , 2008, American Journal of Obstetrics and Gynecology.
[7] J. Bonde,et al. Prenatal alcohol exposure and cryptorchidism , 2007, Acta paediatrica.
[8] J. Toppari,et al. Luteinizing hormone in testicular descent , 2007, Molecular and Cellular Endocrinology.
[9] D. Veeramachaneni,et al. Cryptorchidism in common eutherian mammals. , 2007, Reproduction.
[10] J. Olsen,et al. Cryptorchidism According to Maternal Gestational Smoking , 2007, Epidemiology.
[11] J. Toppari,et al. Mild gestational diabetes as a risk factor for congenital cryptorchidism. , 2006, The Journal of clinical endocrinology and metabolism.
[12] M. Vijayan,et al. Salicylate disrupts interrenal steroidogenesis and brain glucocorticoid receptor expression in rainbow trout. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[13] M. Frydenberg,et al. Does Low Participation in Cohort Studies Induce Bias? , 2006, Epidemiology.
[14] M. Albrecht,et al. Cyclooxygenase-2 and prostaglandin F2 alpha in Syrian hamster Leydig cells: Inhibitory role on luteinizing hormone/human chorionic gonadotropin-stimulated testosterone production. , 2006, Endocrinology.
[15] Matthew P Longnecker,et al. Risk factors for cryptorchism among populations at differing risks of testicular cancer. , 2006, International journal of epidemiology.
[16] D. Aronoff,et al. New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases , 2006, Clinical pharmacology and therapy.
[17] Y. Jo,et al. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. , 2005, Molecular endocrinology.
[18] H. Dolk. EUROCAT: 25 years of European surveillance of congenital anomalies , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[19] G. Graham,et al. Mechanism of Action of Paracetamol , 2005, American journal of therapeutics.
[20] Y. Jo,et al. Inhibition of cyclooxygenase-2 activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells. , 2003, Endocrinology.
[21] Henrik Toft Sørensen,et al. The Danish National Birth Cohort - its background, structure and aim , 2001, Scandinavian journal of public health.
[22] L. de Jong-van den Berg,et al. Do Pregnant Women Report Use of Dispensed Medications? , 2001, Epidemiology.
[23] L. Guidetti,et al. Aspirin inhibits androgen response to chorionic gonadotropin in humans. , 1999, American journal of physiology. Endocrinology and metabolism.
[24] P. Sparén,et al. Risk factor patterns for cryptorchidism and hypospadias. , 1999, Epidemiology.
[25] T. F. Andersen,et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.
[26] T. K. Jensen,et al. Risk factors for cryptorchidism and hypospadias. , 1999, The Journal of urology.
[27] M J Goldacre,et al. Prenatal risk factors for cryptorchidism: a record linkage study. , 1998, Paediatric and perinatal epidemiology.
[28] M. Valença,et al. Arachidonic acid and its metabolites effects on testosterone production by rat Leydig cells , 1995, Journal of endocrinological investigation.
[29] P. Reddanna,et al. Arachidonic acid metabolites as intratesticular factors controlling androgen production. , 1993, International journal of andrology.
[30] P. Merlob,et al. NSAIDs: Maternal and Fetal Considerations , 1992, American journal of reproductive immunology.
[31] W. Rayburn,et al. Acetaminophen pharmacokinetics: comparison between pregnant and nonpregnant women. , 1986, American journal of obstetrics and gynecology.
[32] I. Huhtaniemi,et al. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. , 1977, The Journal of clinical endocrinology and metabolism.
[33] K. Christensen,et al. Cryptorchidism concordance in monozygotic and dizygotic twin brothers, full brothers, and half-brothers. , 2010, Fertility and sterility.
[34] R. Hoover,et al. Urogenital Abnormalities in Men Exposed to Diethylstilbestrol in Utero: A Cohort Study , 2009 .
[35] J. Thorup,et al. The true incidence of cryptorchidism in Denmark. , 2008, The Journal of urology.
[36] J. Clements,et al. Studies on human sexual development. III. Fetal pituitary and serum, and amniotic fluid concentrations of LH, CG, and FSH. , 1976, The Journal of clinical endocrinology and metabolism.